Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
AptarGroup, Inc. is a global manufacturer of dispensing, drug delivery, and active packaging solutions, serving the pharmaceutical, beauty, personal care, food, and beverage industries. The company designs and produces a wide range of systems that enable the safe, precise, and convenient delivery of liquid and solid products, including pumps, aerosol valves, closures, elastomer components, and drug delivery devices. Its primary revenue drivers are proprietary dispensing technologies used in pharmaceutical drug delivery systems and branded consumer packaging applications.
Founded in 1940 and originally operating as a division of Kohlberg Kravis Roberts & Co., Aptar became an independent public company in 1992 following its spin-off from Triangle Industries, Inc. Over time, the company evolved from a primarily packaging-focused manufacturer into a technology-driven solutions provider with a strong emphasis on regulated pharmaceutical markets. Aptar’s strategic advantage lies in its deep engineering expertise, long-term customer relationships, and high switching costs associated with regulatory approvals and customized dispensing systems.
Business Operations
AptarGroup operates through three primary business segments: Aptar Pharma, Aptar Beauty, and Aptar Food + Beverage. Aptar Pharma is the largest and fastest-growing segment, generating revenue through nasal spray pumps, inhalers, injectable components, and active material science solutions used by pharmaceutical and biotechnology companies. Aptar Beauty supplies dispensing systems, airless packaging, and closures for beauty, personal care, and home care brands, while Aptar Food + Beverage focuses on closures, valves, and dispensing solutions for packaged food and beverage applications.
The company operates manufacturing and R&D facilities across North America, Europe, Asia, and Latin America, enabling localized production and regulatory compliance. Aptar controls a significant portfolio of proprietary technologies and patents, particularly in drug delivery and elastomer formulations. Its operations are supported by wholly owned subsidiaries and specialized units, including Nanopharma, Gateway Analytical, and FusionPKG, which enhance its capabilities in material science, analytical services, and custom beauty packaging.
Strategic Position & Investments
Aptar’s strategic direction emphasizes expanding its presence in high-growth, high-margin pharmaceutical and healthcare markets while maintaining selective innovation in beauty and food packaging. Growth initiatives include increased investment in biologics-compatible drug delivery systems, digital health-enabled devices, and sustainable packaging solutions. The company has consistently allocated capital toward R&D and capacity expansion aligned with long-term pharmaceutical customer contracts.
Notable acquisitions have played a key role in this strategy, including Nanopharma and Gateway Analytical, which strengthen Aptar’s capabilities in formulation development, particle engineering, and regulatory support services for drug developers. Aptar is also actively involved in emerging sectors such as nasal drug delivery for systemic therapies, injectable elastomer components for biologics, and recyclable or reduced-material packaging technologies.
Geographic Footprint
AptarGroup is headquartered in Crystal Lake, Illinois, United States, and operates more than 50 manufacturing and development facilities globally. The company maintains a strong presence across North America and Europe, which together represent the majority of its revenue, particularly in pharmaceutical applications. Asia-Pacific and Latin America serve as important growth regions, supporting both multinational customers and regional consumer brands.
The company’s global footprint allows it to serve regulated pharmaceutical markets with localized manufacturing and technical support while leveraging global scale in procurement, R&D, and innovation. Aptar’s international operations also support multinational product launches and long-term supply agreements with leading healthcare and consumer goods companies.
Leadership & Governance
AptarGroup is led by an executive team with extensive experience in engineering, life sciences, and global manufacturing. The leadership emphasizes operational excellence, disciplined capital allocation, and innovation-driven growth, with a stated focus on sustainability and patient-centric healthcare solutions.
Key executives include:
- Stephan B. Tanda – President and Chief Executive Officer
- James A. Farrell, Jr. – Executive Vice President and Chief Financial Officer
- Brian J. Luedde – Executive Vice President, Aptar Pharma
- Sanjay Patel – Executive Vice President, Aptar Beauty
- Paul T. Hirtz – Executive Vice President, Aptar Food + Beverage
The company operates under a traditional U.S. public company governance structure, with oversight provided by an independent board of directors and compliance with SEC filings and global regulatory standards.